These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
193 related items for PubMed ID: 17044348
21. At what age do children start taking daily asthma medicines on their own? Orrell-Valente JK, Jarlsberg LG, Hill LG, Cabana MD. Pediatrics; 2008 Dec; 122(6):e1186-92. PubMed ID: 19047221 [Abstract] [Full Text] [Related]
24. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study. Nathan RA, Rooklin A, Schoaf L, Scott C, Ellsworth A, House K, Dorinsky P. Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581 [Abstract] [Full Text] [Related]
29. Complementary and alternative medicine use and adherence to asthma medications among Latino and non-Latino white families. McQuaid EL, Fedele DA, Adams SK, Koinis-Mitchell D, Mitchell J, Kopel SJ, Seifer R, Jandasek B, Fritz GK, Canino G. Acad Pediatr; 2014 Jan; 14(2):192-9. PubMed ID: 24602583 [Abstract] [Full Text] [Related]
30. Comparison of patient-reported outcomes during treatment with adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler versus fixed-dose fluticasone propionate/salmeterol dry powder inhaler in patients with asthma. O'Connor RD, Patrick DL, Parasuraman B, Martin P, Goldman M. J Asthma; 2010 Mar; 47(2):217-23. PubMed ID: 20170333 [Abstract] [Full Text] [Related]
31. The therapeutic effects of inhaled long-acting beta2-adrenergics (LABA) and corticosteroids (ICS) are not affected by their inhalation sequence in moderate/persistent asthma. Dal Negro RW, Micheletto C, Tognella S, Trevisan F, Guerriero M. Eur Ann Allergy Clin Immunol; 2006 May; 38(5):153-7. PubMed ID: 17058847 [Abstract] [Full Text] [Related]
32. Salmeterol/fluticasone propionate versus fluticasone propionate plus montelukast: a cost-effective comparison for asthma. Pieters WR, Wilson KK, Smith HC, Tamminga JJ, Sondhi S. Treat Respir Med; 2005 May; 4(2):129-38. PubMed ID: 15813665 [Abstract] [Full Text] [Related]
34. Adding montelukast to fluticasone propionate/salmeterol for control of asthma and seasonal allergic rhinitis. Katial RK, Oppenheimer JJ, Ostrom NK, Mosnaim GS, Yancey SW, Waitkus-Edwards KR, Prillaman BA, Ortega HG. Allergy Asthma Proc; 2010 May; 31(1):68-75. PubMed ID: 20167147 [Abstract] [Full Text] [Related]
35. Cost-effectiveness comparison of salmeterol/fluticasone propionate versus montelukast in the treatment of adults with persistent asthma. Sheth K, Borker R, Emmett A, Rickard K, Dorinsky P. Pharmacoeconomics; 2002 May; 20(13):909-18. PubMed ID: 12381242 [Abstract] [Full Text] [Related]
36. Cost effectiveness of fluticasone propionate plus salmeterol versus fluticasone propionate plus montelukast in the treatment of persistent asthma. O'Connor RD, Nelson H, Borker R, Emmett A, Jhingran P, Rickard K, Dorinsky P. Pharmacoeconomics; 2004 May; 22(12):815-25. PubMed ID: 15294013 [Abstract] [Full Text] [Related]
37. The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma. FitzGerald JM, Boulet LP, Follows RM. Clin Ther; 2005 Apr; 27(4):393-406. PubMed ID: 15922813 [Abstract] [Full Text] [Related]
39. [A fixed combination of fluticasone and salmeterol permits better control of asthma than a beclomethasone dipropionate and montelukast combination]. Grosclaude M, Cerruti JL, Delannay B, Hérent M, Spilthooren F, Desfougères JL. Eur Ann Allergy Clin Immunol; 2003 Nov; 35(9):356-62. PubMed ID: 14716965 [Abstract] [Full Text] [Related]
40. Perception of bronchoconstriction: a complementary disease marker in children with asthma. Nuijsink M, Hop WC, Jongste JC, Sterk PJ, Duiverman AE, Cato Study Group. J Asthma; 2013 Aug; 50(6):560-4. PubMed ID: 23672570 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]